Literature DB >> 4633300

Polymerized ragweed antigen E. I. Preparation and immunologic studies.

R Patterson, I M Suszko, F C McIntire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4633300

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  Isotype-selective abrogation of established IgE responses.

Authors:  K T HayGlass; W Stefura
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Quantitative relationships between IgE antibody and blocking antibodies specific for antigen E in patients given immunotherapy with ragweed antigen E.

Authors:  C R Zeiss; W J Metzger; D Levitz
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

Review 3.  Allergenic extracts.

Authors:  R E Reisman
Journal:  Bull N Y Acad Med       Date:  1981-09

4.  Antigen-specific modulation of murine IgE and IgG2a responses with glutaraldehyde-polymerized allergen is independent of MHC haplotype and Igh allotype.

Authors:  K T Hayglass; W Stefura
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

5.  Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice.

Authors:  M Haak-Frendscho; R Saban; R L Shields; P M Jardieu
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

6.  Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo.

Authors:  M Haak-Frendscho; K Robbins; R Lyon; R Shields; J Hooley; M Schoenhoff; P Jardieu
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

7.  Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses.

Authors:  K T HayGlass; B P Stefura
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

8.  Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo.

Authors:  X Yang; R S Gieni; T R Mosmann; K T HayGlass
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.